Net Income - InterCure Ltd (NASDAQ:INCR) - Alpha Spread
I

InterCure Ltd
NASDAQ:INCR

Watchlist Manager
InterCure Ltd
NASDAQ:INCR
Watchlist
Price: 1.86 USD Market Closed
Market Cap: 84.8m USD
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InterCure Ltd
Net Income Peer Comparison

Comparables:
TEVA
RDHL
SLGL
MDWD
R
REKA

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
NASDAQ:INCR
Net Income
-â‚Ş63.5m
CAGR 3-Years
-21%
CAGR 5-Years
-38%
CAGR 10-Years
-25%
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Net Income
-$773m
CAGR 3-Years
42%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Redhill Biopharma Ltd
NASDAQ:RDHL
Net Income
-$30.2m
CAGR 3-Years
32%
CAGR 5-Years
5%
CAGR 10-Years
-15%
Sol Gel Technologies Ltd
NASDAQ:SLGL
Net Income
-$14.9m
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Net Income
-$20m
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
-3%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Net Income
-â‚Ş6.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is InterCure Ltd's Net Income?
Net Income
-63.5m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Net Income amounts to -63.5m ILS.

What is InterCure Ltd's Net Income growth rate?
Net Income CAGR 10Y
-25%

The average annual Net Income growth rates for InterCure Ltd have been -21% over the past three years , -38% over the past five years , and -25% over the past ten years .

Back to Top